CliffBio
small molecule

DYMISTA

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Loss of exclusivityAugust 2026latest FDA-listed patent expiry
CompanyMYLAN SPECIALTY LP

Drug detail

Brand nameDYMISTA
Active ingredientAZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
Strength0.137MG/SPRAY;0.05MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalMay 2012
Marketing statusRX

Listed patents

PatentExpiresType
8168620*PEDAugust 2026—
8168620February 2026product

More from MYLAN SPECIALTY LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found